Surmodics Merges with Biocoat; Forms Surmodics Services & Technologies Division

GTCR Affiliate Acquires Surmodics, Inc.

November 10, 2025

Medical Devices

Surmodics announced that a U.S. district court denied the FTC and certain state regulators’ request for a preliminary injunction to block the company’s proposed acquisition by an affiliate of GTCR. Surmodics said the merger remains subject to a temporary restraining order and customary closing conditions, with the company expecting to move toward closing promptly.

GTCR Invests in Biocoat

November 2, 2022

Medical Devices

GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.

GTCR to Acquire Surmodics for $43.00 per Share; Equity Value Approximately $627M

May 29, 2024

Medical Devices

GTCR, a leading private equity firm, will acquire Surmodics, a Minnesota-based medical device and in vitro diagnostic technologies company, for $43.00 per share in cash, implying an approximate equity value of $627 million. The transaction, unanimously approved by Surmodics' board, is expected to close in the second half of 2024 and will take Surmodics private following customary regulatory and shareholder approvals.

Masco Group Acquires Techniserv, Inc.

June 6, 2025

Manufacturing

Masco Group has acquired Techniserv, Inc., a U.S.-based provider of bioreactor and bioprocess systems, to strengthen its U.S. presence and expand its upstream and downstream processing capabilities. Techniserv will continue operating under its current leadership as part of Masco Group's Process Business Unit, bringing a 62,000 sq. ft. Pennsylvania facility and service team to Masco's global platform.

Biocomposites Acquires Remaining Shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L.

September 18, 2024

Medical Devices

Biocomposites has acquired the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L., gaining full control of the SYNICEM™ and Subiton antibiotic bone cement and preformed spacer product ranges. The deal consolidates Biocomposites' capabilities in infection-management bone cements and spacers and will allow the company to leverage its global distribution network to expand these products' reach.

Surmodics Acquires Vetex Medical Limited

July 6, 2021

Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.